BWY-36362-17751
3 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 800 / CO
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
XU2-25664-37897
Child or adolescent in my care · Male · 2022-06-20
Timeline
-
2021-01-21
Registered in v-safe
-
2021-01-21
Dose 1 — Pfizer-BioNTech
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-27
- 2021-01-28
- 2021-02-04
-
2021-02-11
Dose 2 — Pfizer-BioNTech
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
-
2021-05-13
Survey response — 3 months, dose 2MedDRA: Delivery — Feeling: Good · Be unable to workFree text: Delivered baby at 39 weeks; vaginal birth no complications for mom or babyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-11-05
Dose 3 — Pfizer-BioNTech
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Pfizer-BioNTech | |
| 2 | 2021-02-11 | Pfizer-BioNTech | |
| 3 | 2021-11-05 | Pfizer-BioNTech | No |
Free text
Release 8 — 3 months, dose 2
Symptoms: Delivered baby at 39 weeks; vaginal birth no complications for mom or baby
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release